{
    "root": "8e188038-114a-4180-a9e4-e1ea6c9bdae2",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Digoxin",
    "value": "20250325",
    "ingredients": [
        {
            "name": "DIGOXIN",
            "code": "73K4184T59",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_4551"
        },
        {
            "name": "ALCOHOL",
            "code": "3K9958V90M",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30879"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "SODIUM PHOSPHATE, DIBASIC, ANHYDROUS",
            "code": "22ADO53M6F",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_37586"
        },
        {
            "name": "ANHYDROUS CITRIC ACID",
            "code": "XF417D3PSL",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30769"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_15377"
        },
        {
            "name": "CITRIC ACID MONOHYDRATE",
            "code": "2968PHW8QP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_31404"
        },
        {
            "name": "SODIUM PHOSPHATE",
            "code": "SE337SVY37",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_37586"
        }
    ],
    "indications": {
        "text": "digoxin cardiac glycoside indicated : treatment mild moderate heart failure adults . ( 1.1 ) control resting ventricular rate adults chronic atrial fibrillation . ( 1.2 )",
        "doid_entities": [
            {
                "text": "atrial fibrillation (DOID:0060224)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_0060224"
            }
        ],
        "orphanet_entities": [
            {
                "disease": "chronic atrial fibrillation",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_334"
            }
        ]
    },
    "contraindications": {
        "text": "digoxin dose based patient-specific factors ( age , lean body weight , renal function , etc . ) . full prescribing information . monitor toxicity therapeutic effect . ( 2 ) intravenous preferable intramuscular . avoid bolus . ( 2 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "digoxin injection , usp available : 500 mcg/2 ml ( 250 mcg/ml ) ampuls packaged 25s ( ndc 0641-6184-25 ) store 20\u02da-25\u02dac ( 68\u02da-77\u02daf ) , excursions permitted 15\u02da-30\u02dac ( 59\u02da-86\u02daf ) [ usp controlled room temperature ] . protect light .",
    "adverseReactions": "digoxin contraindicated patients : ventricular fibrillation [ ( 5.1 ) ] known hypersensitivity digoxin ( seen include unexplained rash , swelling mouth , lips throat difficulty breathing ) . hypersensitivity reaction digitalis preparations usually constitutes contraindication digoxin .",
    "indications_original": "Digoxin\u00a0is a cardiac glycoside indicated for: Treatment of mild to moderate heart failure in adults. ( 1.1 ) Control of resting ventricular rate in adults with chronic atrial fibrillation. ( 1.2 )",
    "contraindications_original": "Digoxin dose is based on patient-specific factors (age, lean body weight, renal function, etc.). See full prescribing information. Monitor for toxicity and therapeutic effect. ( 2 ) Intravenous administration is preferable to intramuscular. Avoid bolus administration. ( 2 )",
    "warningsAndPrecautions_original": "Digoxin Injection, USP is available as:\n                  500 mcg/2 mL (250 mcg/mL) ampuls packaged in 25s (NDC 0641-6184-25)\n                  \n                     Store at 20\u02da-25\u02daC (68\u02da-77\u02daF), excursions permitted to 15\u02da-30\u02daC (59\u02da-86\u02daF) [see USP Controlled Room Temperature]. Protect from light.",
    "adverseReactions_original": "Digoxin\u00a0is contraindicated in patients with:\n                  \n                     Ventricular fibrillation [see Warnings and Precautions (5.1)]\n                     \n                     Known hypersensitivity to digoxin (reactions seen include unexplained rash, swelling of the mouth, lips or throat or a difficulty in breathing). A hypersensitivity reaction to other digitalis preparations usually constitutes a contraindication to digoxin.",
    "drug": [
        {
            "name": "Digoxin",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_4551"
        }
    ]
}